Evaluates TPP riboswitch for gene expression modulation in yeast, suggesting potential for synthetic biology applications.
Komagataella phaffii (syn. Pichia pastoris) is a methylotrophic yeast widely established as host for recombinant protein production and increasingly used as cell factory for C1-based metabolites. Nevertheless, synthetic biology tools for regulating protein expression in this host remain limited, relying largely on promoters of genes from central carbon metabolism. Riboswitches, i.e. mRNA elements that regulate translation or splicing via ligand-dependent folding, offer a complementary layer of regulation, yet remain unused in K. phaffii synthetic biology. In the methylotrophic yeast Ogataea polymorpha, an intron within the DUR31 gene acts as a thiamine pyrophosphate (TPP) riboswitch, downregulating gene expression through alternative splicing, and retaining a premature stop codon in response to exogenous thiamine. We evaluated this TPP riboswitch in K. phaffii as a tool to modulate expression from the glycolytic GAP promoter. Using EGFP and destabilised UBIYΔkGFP⁎ as reporters in combination with flow cytometry, we show that the orthogonal riboswitch is functional in K. phaffii. Like many other described riboswitches, the system exhibits substantial basal (leaky) expression and cannot be considered a tight molecular on/off switch. RT-PCR confirmed the presence of both spliced and unspliced transcripts in the cells regardless of external thiamine supplementation. Unexpectedly, inserting an additional exon upstream of the riboswitch intron abolished detectable downstream protein production, indicating that splicing efficiency is strongly influenced by the local sequence context of the splice sites.
No takes yet. Share an insight, caveat, or question.
Małecki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: